Jak3-KO 基因敲除小鼠

1. Quero, Lilian, Tiaden, André N, Hanser, Edveena, Hall, Jonathan, Kyburz, Diego. 2020. miR-221-3p Drives the Shift of M2-Macrophages to a Pro-Inflammatory Function by Suppressing JAK3/STAT3 Activation. In Frontiers in immunology, 10, 3087. doi:10.3389/fimmu.2019.03087. https://pubmed.ncbi.nlm.nih.gov/32047494/

2. Leonard, Warren J, Lin, Jian-Xin, O'Shea, John J. . The γc Family of Cytokines: Basic Biology to Therapeutic Ramifications. In Immunity, 50, 832-850. doi:10.1016/j.immuni.2019.03.028. https://pubmed.ncbi.nlm.nih.gov/30995502/

3. Tokgun, Pervin Elvan, Karagenc, Nedim, Karasu, Uğur, Akca, Hakan, Yüksel, Selçuk. 2023. Treatment of STING-associated vasculopathy with onset in infancy in patients carrying a novel mutation in the TMEM173 gene with the JAK3-inhibitor tofacitinib. In Archives of rheumatology, 38, 461-467. doi:10.46497/ArchRheumatol.2023.9927. https://pubmed.ncbi.nlm.nih.gov/38046254/

4. Xu, P P, Zhou, T, Xu, Y Y, Ouyang, J, Chen, B. . [Ruxolitinib combined with venetoclax and azacitidine in the treatment of refractory T-ALL patients with JAK1, JAK3, and STAT5B gene mutations: a case report and literature review]. In Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 45, 872-875. doi:10.3760/cma.j.cn121090-20240412-00138. https://pubmed.ncbi.nlm.nih.gov/39414615/

5. Velatooru, Loka Reddy, Hu, Cheng Hui, Bijani, Pedram, Duvic, Madeleine, Ni, Xiao. 2023. New JAK3-INSL3 Fusion Transcript-An Oncogenic Event in Cutaneous T-Cell Lymphoma. In Cells, 12, . doi:10.3390/cells12192381. https://pubmed.ncbi.nlm.nih.gov/37830594/